MedPlus profit jumps 46% to ₹2,196.1 mn, revenue up 12% to ₹68,924.6 mn
Annual results show strong margin expansion; profit growth outpaces revenue by nearly 4x.
— 1 earlier story on Medplus Health Services Ltd. →What's new
- Consolidated net profit rose 46.1% to ₹2,196.1 million for FY26.
- Revenue grew 12.3% to ₹68,924.6 million.
- Board reappointed the managing director for five years and appointed two new independent directors.
Why it matters
MedPlus is demonstrating that scale in pharmacy retail can drive margin expansion. With profit growth far exceeding revenue, the company shows improving operational efficiency. The governance changes ensure leadership continuity, though the company secretary's resignation is routine.
What we're watching
- Whether MedPlus can sustain this margin expansion in a competitive pharmacy market.
- Impact of new independent directors on board governance.
- Any updates on store expansion plans or online strategy in upcoming quarters.
The full read
MedPlus closed FY26 with net profit of ₹2,196.1 million, up 46.1% on revenue of ₹68,924.6 million, which grew 12.3%. The profit growth was nearly four times the revenue pace, indicating strong cost control and product mix improvement. The board renewed the managing director's tenure for five years and added two new independent directors, signaling stability. The company secretary resigned, a routine change. For a mid-cap pharmacy retailer, these results confirm that operational efficiency is improving as the network scales. The next test is whether this trajectory can hold as competition intensifies.